Literature DB >> 11434686

Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels.

H Ceelie1, R M Bertina, A van Hylckama Vlieg, F R Rosendaal, H L Vos.   

Abstract

To find genetic causes of high plasma prothrombin levels, an established prothrombotic risk factor. we searched for sequence variations in the prothrombin gene. We selected subjects with the 20210-GG genotype (since the 20210-A allele is already known to be associated with high levels) and elevated prothrombin levels (> or = 130 U/dl) from the Leiden Thrombophilia Study (LETS). No mutations were found in the 1 kb promoter region of the prothrombin gene in seven individuals with an isolated high prothrombin level. Comparison of the allelic frequencies of four different polymorphisms in the prothrombin gene in healthy volunteers and in the control subjects among the selected LETS individuals indicated a higher frequency of the 19911-G allele in the latter group (allele frequency 52 vs. 78%, respectively). Homozygous carriers of the 19911-G allele had 8 U/dl higher plasma prothrombin levels than 19911-AA carriers. This difference in prothrombin levels did not affect the thrombotic risk in 20210-GG carriers. In heterozygous 20210-A carriers the odds ratio increased from 1.6 (95% CI: 0.6-4.3) in subjects with 19911-A to 4.7 (1.6-14.0) in subjects with 19911-G on the other prothrombin allele.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434686

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Functional polymorphisms of the coagulation factor II gene (F2) and susceptibility to systemic lupus erythematosus.

Authors:  F Yesim K Demirci; Amy S Dressen; Candace M Kammerer; M Michael Barmada; Amy H Kao; Rosalind Ramsey-Goldman; Susan Manzi; M Ilyas Kamboh
Journal:  J Rheumatol       Date:  2011-01-15       Impact factor: 4.666

2.  Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor.

Authors:  Garth W Tormoen; Ayesha Khader; András Gruber; Owen J T McCarty
Journal:  Phys Biol       Date:  2013-04-15       Impact factor: 2.583

3.  Prothrombin 20210 G/A defect as a cause of mesenteric venous infarction: report of a case.

Authors:  Erdal Karagulle; Emin Turk; Huseyin Savas Gokturk; Erkan Yildirim; Gokhan Moray
Journal:  Surg Today       Date:  2007-03-09       Impact factor: 2.549

4.  The 3' end prothrombin gene variants in serbian patients with idiopathic thrombophilia.

Authors:  M Aradjanski; V Djordjevic; I Pruner; B Tomic; M Gvozdenov; M Kovac; D Radojkovic
Journal:  Balkan J Med Genet       Date:  2015-04-10       Impact factor: 0.519

Review 5.  Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond.

Authors:  Sven Danckwardt; Matthias W Hentze; Andreas E Kulozik
Journal:  J Mol Med (Berl)       Date:  2013-08-17       Impact factor: 4.599

6.  C20209T prothrombin gene mutation associated deep venous thrombosis in a hemodialysis patient.

Authors:  Samer Bani-Hani; Omar Siddiqui; Anami Patel; Arif Showkat
Journal:  Clin Nephrol Case Stud       Date:  2014-01-15

7.  A deep vein thrombosis caused by 20209C>T mutation in homozygosis of the prothrombin gene in a Caucasian patient.

Authors:  Silvia Izquierdo Alvarez; Eva Barrio Ollero; Francisco Miguel Llinares Sanjuan; Fabiola Lorente Martínez; María Teresa Calvo Martín
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.